Internationally known “One Health” U.S. Physician Discusses Antimicrobial Resistance and the Critical role for a One Health Approach on National Public Radio (NPR)’s Broadcast ‘Science Friday’ Broadcast 09/16/2016 “This past August, the World Health Organization (WHO) issued new guidelines for treating gonorrhea with antibiotics. It warned that the standard drugs used to treat the STD are losing their effectiveness due to increasing resistance. The WHO now recommends using a combination of drugs to treat bacteria responsible for the infection. The announcement was the latest in a string of bad news related to the burgeoning problem of antibiotic resistance. Last fall, researchers in China discovered bacteria resistant to a last-line antibiotic, colistin; now colistin-resistant E. coli has cropped up in more than 30 countries around the world, including the U.S. The issue has escalated to the point where the U.N., a body typically concerned with global wars and economics, will meet next week to discuss the problem of antibiotic resistance.   Can superbugs be treated through international cooperation? Antimicrobial resistance may not be as polarizing an issue as, say, climate change, but Laura Kahn, author of One Health and the Politics of Antimicrobial Resistance [], says it’s still a murky political battlefield. Kahn joins us to discuss why this is a global issue requiring global cooperation. ...” SEE, turn on your computer’s sound system and click on the red circle containing the arrow.  Then listen to Speaker Laura H. Kahn, MD, MPH, MPP, Research Scholar, Program on Science and Global Security, Woodrow Wilson School of Public and International Affairs, Princeton University, Princeton, New Jersey (USA). Dr. Kahn is a co-founder of the One Health Initiative team & One Health Initiative website and Columnist, Bulletin of the Atomic Scientists